🇺🇸 FDA
Patent

US 8501943

Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor

granted A61PA61P17/06A61P19/00

Quick answer

US patent 8501943 (Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor) held by Almirall, S.A. expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P17/06, A61P19/00, A61P19/02, A61P25/00